Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carnivora Research International is a private U.S.-based nutraceutical company that markets Carnivora, a dietary supplement derived from Dionaea muscipula (Venus flytrap). The company sells capsule and liquid extract formulations positioned for immune system support and broader wellness, along with adjunct products such as lymphatic support and turmeric-based supplements. Carnivora traces the product's development to physician Dr. Helmut Keller in Europe in the late 1970s and says manufacturing now occurs in the United States using its original European technology. The business appears to operate primarily as a direct-to-consumer and practitioner-oriented commercial supplement company rather than a clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carnivora Research International.